SCHEMBL2016006

SCHEMBL2016006

CN(C(=O)c1cnn2ccccc12)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.60
HCRTR2 O43614 2/20 0.60
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 6/20 0.42
HSD17B10 Q99714 3/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KLF5 Q13887 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 1/20 0.39
DRD2 P14416 4/20 0.39
DRD4 P21917 4/20 0.39
DRD3 P35462 4/20 0.39
DRD1 P21728 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015123 0.88 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9AKDM4E
SCHEMBL6919977 0.87 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9AKDM4E
SCHEMBL2011775 0.87 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9AKDM4E
SCHEMBL2054339 0.85 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2054337 0.85 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012675 0.84 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012147 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2051271 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2011272 0.82 HCRTR1 (0.62) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL13139060 0.82 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed